Hyperphosphatemia

• FDA label_change · 2024-08-27
  FDA Approved: VELPHORO — Supplemental Application (Fresenius Medical Care Renal Therapies Group, LLC)

  FDA approved a supplemental application for Velphoro (sucroferric oxyhydroxide) to update the product labeling.

• FDA label_change · 2020-04-30
  FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)

  The FDA approved a supplemental application for sevelamer hydrochloride (Sanofi) resulting in changes to the product’s labeling.

• FDA label_change · 2020-04-10
  FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Exelan Pharmaceuticals Inc.)

  FDA approved a supplemental application for Sevelamer carbonate from Exelan Pharmaceuticals Inc., resulting in updated labeling.

• FDA label_change · 2017-08-03
  FDA Approved: VELPHORO — Supplemental Application (Fresenius Medical Care Renal Therapies Group, LLC)

  FDA approved a supplemental application for Velphoro (sucroferric oxyhydroxide) to update the product labeling.

• FDA label_change · 2015-08-27
  FDA Approved: FERRIC CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  FDA approved a supplemental application for Ferric Citrate from Mylan Pharmaceuticals, representing a label change to the product.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2011-06-16
  FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)

  FDA approved a supplemental application for sevelamer carbonate (Renvela) submitted by Sanofi-Aventis U.S. LLC to update the product labelin…